4//SEC Filing
M28 Capital Management LP 4
Accession 0000899243-22-024021
CIK 0001832038other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:40 PM ET
Size
12.4 KB
Accession
0000899243-22-024021
Insider Transaction Report
Form 4
Elia Marc
DirectorOther
Transactions
- Award
Stock Option (Right to Buy)
2022-06-22+150,000→ 150,000 totalExercise: $3.09Exp: 2032-06-21→ Common Stock (150,000 underlying)
Transactions
- Award
Stock Option (Right to Buy)
2022-06-22+150,000→ 150,000 totalExercise: $3.09Exp: 2032-06-21→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 22, 2022 and vests over a three-year period, with one-third of the shares subject to the grant vesting on the first anniversary of the grant date and 1/36th of the shares subject to the grant vesting in equal monthly installments thereafter, subject to continued service through each vesting date. The grant was awarded to Marc Elia ("Mr. Elia"). Mr. Elia is deemed to hold the grant for the benefit of M28 Capital Management LP ("M28 Capital Management") and the funds managed by M28 Capital Management.
Issuer
Adagio Therapeutics, Inc.
CIK 0001832038
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001807489
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:40 PM ET
- Size
- 12.4 KB